论文部分内容阅读
目的评价肝癌实施化疗栓塞术联合射频消融治疗的临床效果。方法 92例肝癌患者纳入研究,按随机数字表法分为两组;对照组46例单用化疗栓塞术治疗,观察组46例实施化疗栓塞术联合射频消融治疗,对比两组患者的临床治疗效果。结果治疗前,两组患者甲胎蛋白、肿瘤最大直径及丙氨酸氨基转移酶三项指标比较差异未见统计学意义(P>0.05);治疗后,两组患者的丙氨酸氨基转移酶比较,差异未见统计学意义(P>0.05),但观察组的甲胎蛋白明显低于对照组(P<0.05),肿瘤最大直径明显小于对照组(P<0.05)。观察组总缓解率为84.78%,明显高于对照组(52.17%,P<0.05)。此外,两组不良反应发生率比较,差异未见统计学意义(P>0.05)。结论对于肝癌患者,实施化疗栓塞术联合射频消融治疗疗效显著,值得推广应用。
Objective To evaluate the clinical effect of chemoembolization combined with radiofrequency ablation in the treatment of liver cancer. Methods Ninety-two patients with hepatocellular carcinoma (HCC) were enrolled in the study and randomly divided into two groups according to the random number table. Forty-six patients in the control group were treated with chemoembolization alone. Forty-six patients in the observation group received chemoembolization combined with radiofrequency catheter ablation. . Results Before treatment, there was no significant difference in alpha-fetoprotein, maximum diameter of tumor and alanine aminotransferase between the two groups (P> 0.05). After treatment, the alanine aminotransferase (P> 0.05). However, the alpha-fetoprotein in the observation group was significantly lower than that in the control group (P <0.05), and the maximum diameter of the tumor was significantly smaller than that in the control group (P <0.05). The total remission rate of the observation group was 84.78%, which was significantly higher than that of the control group (52.17%, P <0.05). In addition, the incidence of adverse reactions in both groups, the difference was not statistically significant (P> 0.05). Conclusion For patients with liver cancer, the implementation of chemoembolization combined with radiofrequency ablation treatment is significant, it is worth to promote the application.